Latest News

Guthrie Introduces Bipartisan Lower Insulin Costs Now Act

Washington, December 18, 2019

UPDATE: The Lower Insulin Costs Now Act was included in the Fiscal Year 2020 Appropriations package and was signed into law by President Trump on Friday, December 20, 2019.

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), top Republican on the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, this week introduced the bipartisan Lower Insulin Costs Now Act, along with U.S. Reps. Lauren Underwood (IL-14), Jan Schakowsky (IL-09), and Mike Kelly (PA-16).

“Insulin hasn’t changed in decades, so there is no reason why the price of it has suddenly spiked,” said Guthrie, who led a subcommittee investigation into the rising costs of insulin earlier this year. “Our investigation into the price of insulin found that list prices have climbed, hurting the uninsured and underinsured who are forced to pay the high cost. The Lower Insulin Costs Now Act will help bring generics to the market faster so patients are paying lower costs. I was proud to join Reps. Schakowsky, Underwood, and Kelly in introducing this commonsense legislation to make insulin more affordable.”

More than 30 million Americans are living with type I or type II diabetes, including one in four seniors and a growing number of children. Diabetes is a life-threatening disease that can lead to premature death and exacerbate other chronic conditions. The Lower Insulin Costs Now Act would reduce the cost of insulin by helping lower-cost, generic insulin become available to consumers more quickly.

In addition to his subcommittee’s investigation into the cost of insulin, Guthrie joined with his fellow leaders on the Energy and Commerce Committee last week to press insurance companies for answers on their role in the rising cost of insulin.